Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies

The presence of sMPMTs was not a significant risk factor for patients with newly diagnosed hematological malignancies. It is important to provide adequate treatment for both hematological malignancies and solid tumors at the physician's discretion.